Advanced Biomedical Technologies Inc. (ABMT)
OTCQB OTCQB Primary Summary
Advanced Biomedical Technologies Inc. (ABMT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Advanced Biomedical Technologies Inc. ever had a stock split?
Advanced Biomedical Technologies Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Hui Wang CEO | OTCQB Exchange | 00752M101 CUSIP |
| US Country | 17 Employees | - Last Dividend | 13 Mar 2009 Last Split | - IPO Date |
Overview
Advanced Biomedical Technologies, Inc. is a development stage company focusing on the design, development, manufacture, and marketing of innovative biomaterial internal fixation devices. Initially established as Geostar Mineral Corporation, the company underwent a strategic rebranding to Advanced Biomedical Technologies, Inc. in March 2009, aligning its name with its specialized focus within the biomedical field. The foundation of the company dates back to 2002, with its headquarters in New York, New York. Through its cutting-edge products, the company aims to cater to the needs of patients requiring orthopedic trauma, sports-related treatments, cartilage repair, and reconstructive dental procedures, ensuring quality and reliability in its offerings.
Products and Services
- Polymer Osteosynthesis Devices:
- Cartilage Repair and Related Treatments:
- Reconstructive Dental Procedures:
These devices include a range of surgical implants such as screws, binding wires, rods, and other related medical devices. Designed using advanced biomaterials, these osteosynthesis devices are critically important for the internal fixation process, making them invaluable in treatments for orthopedic trauma and sports-related injuries. The innovation behind these devices focuses on enhancing the healing process while ensuring strength and flexibility, which are paramount in the recovery of bone tissue.
Advanced Biomedical Technologies, Inc. leverages its expertise in biomaterials to offer solutions that assist in the repair and regeneration of cartilage. These solutions are tailored to meet the specific needs of patients undergoing treatments for injuries or conditions affecting cartilage, thereby facilitating improved outcomes and recovery rates. The emphasis is on developing products that restore functionality and reduce the overall recovery time for patients.
The company extends its biomaterial technology to the field of dentistry, providing devices that are used in reconstructive dental procedures. These include screws and rods designed to support the reconstructive process, ensuring durability and compatibility with the body’s natural tissues. Such advancements in dental care represent the company’s commitment to diversifying its product offerings, catering to a broader range of medical needs while maintaining a focus on innovation and quality.
